BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30

• Business

  Five Prime Therapeutics Announces the Departure of Dr. Sheila Gujrathi From its Board of Directors

  Five Prime Therapeutics, Inc. announced the departure of Dr. Sheila Gujrathi from the company’s board of directors.

  June 9, 2019

   · 

  2 min read
• Policy

  Acucela Receives Orphan Designation From the EMA for Emixustat for the Treatment of Stargardt Disease

  Acucela Inc., a clinical-stage ophthalmology company and wholly-owned subsidiary of Kubota Pharmaceutical Holdings Co., Ltd., announced that the European Medicines Agency granted orphan designation to Acucela’s leading drug candidate emixustat hydrochloride for the treatment of Stargardt disease.

  June 9, 2019

   · 

  6 min read
• Hamamatsu Photonics K.K. Has Developed a Novel 3D Fluorescence Scanning Method Called “Zyncscan™“ That Performs an X-Z Plane Scan With a Light-Sheet for Cell-Based Fluorescence Assays in Microplates

  Hamamatsu Photonics K.K. has developed a novel 3D fluorescence scanning method called “Zyncscan™” that performs x-z plane scans using a light-sheet for cell-based fluorescence assays in microplates.

  June 9, 2019

   · 

  4 min read
• Biotech Bay

  Two RISE Clinical Trials in Youth and Adults with Impaired Glucose Tolerance or Newly Diagnosed Type 2 Diabetes Reveal Surprising Differences in Beta-Cell (β-cell) Function During and After Treatment

  RISE researchers present Adult Medication Study results at the ADA’s Scientific Sessions and share the first direct comparison for youth and adult studies

  June 9, 2019

   · 

  8 min read
• Job Trends

  About 3 in 100 Medicare Advantage Members Are Familiar with The Blue Button: HealthMine

  Once respondents become familiar with Blue Button, 83% indicated they would consider using it

  June 9, 2019

   · 

  3 min read
• Genetown

  Insulet’s Omnipod® Horizon™ Hybrid Closed-Loop System Improves Glycemic Control in Patients as Young as Two Years Old with Type 1 Diabetes

  Pediatric Scientific Data for the Omnipod Horizon System Presented at the American Diabetes Association’s 79th Scientific Sessions

  June 9, 2019

   · 

  6 min read